Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
CC transcript

ARYx Therapeutics, Inc. (ARYX) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/22/2011 8-K Quarterly results
03/11/2011 8-K Form 8-K - Current report
03/09/2011 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "ARYX THERAPEUTICS INFORMED OF ADDITIONAL DELAY BY FDA AND BEGINS WIND-DOWN OF OPERATIONS"
02/17/2011 8-K Other Events
02/07/2011 8-K Form 8-K - Current report
12/21/2010 8-K Form 8-K - Current report
12/16/2010 8-K Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm...
Docs: "ARYX THERAPEUTICS PROVIDES UPDATE ON COMPANY STATUS"
11/26/2010 8-K Form 8-K - Current report
11/15/2010 8-K Quarterly results
Docs: "ARYX THERAPEUTICS REPORTS THIRD QUARTER RESULTS"
10/08/2010 8-K Form 8-K - Current report
08/16/2010 8-K Form 8-K - Current report
06/03/2010 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Separation and Consulting Agreement, by and between ARYx Therapeutics, Inc. and Peter G. Milner, M.D",
"ARYX ANNOUNCES RESIGNATION OF PETER G. MILNER, PRESIDENT RESEARCH AND DEVELOPMENT"
05/20/2010 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Opinion of Cooley LLP",
"At Market Instrument Sales Agreement, by and among ARYx Therapeutics, Inc., McNicoll, Lewis & Vlak LLC, and Wm Smith & Co"
05/13/2010 8-K Quarterly results
Docs: "ARYX REPORTS FIRST QUARTER 2010 RESULTS OF OPERATIONS - ATI-7505 End of Phase 2 Meeting Held"
04/09/2010 8-K Form 8-K - Current report
03/29/2010 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "ARYX REPORTS FOURTH QUARTER AND FULL YEAR 2009 RESULTS OF OPERATIONS"
03/03/2010 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/19/2010 8-K Form 8-K - Current report
01/05/2010 8-K Other Events, Financial Statements and Exhibits
Docs: "ARYx Therapeutics Receives Guidance on Anticoagulant Agent Tecarfarin"
11/12/2009 8-K Form 8-K - Current report
08/13/2009 8-K Form 8-K - Current report
07/08/2009 8-K Other Events, Financial Statements and Exhibits
Docs: "ARYx Therapeutics Announces Results of Phase 2/3 Clinical Trial on Anticoagulant Agent Tecarfarin"
05/27/2009 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "ARYX THERAPEUTICS, INC. EXECUTIVE SEVERANCE BENEFIT PLAN Section 1. INTRODUCTION."
05/14/2009 8-K Form 8-K -- Current report
03/26/2009 8-K Form 8-K -- Current report
02/24/2009 8-K Form 8-K -- Current report
02/10/2009 8-K Form 8-K -- Current report
01/12/2009 8-K Form 8-K -- Current report
12/18/2008 8-K Form 8-K -- Current report
11/28/2008 8-K Unregistered Sales of Equity Securities
11/17/2008 8-K Form 8-K -- Current report
11/12/2008 8-K Quarterly results
Docs: "Registration Rights Agreement, by and among ARYx Therapeutics, Inc. and the investors identified on the signature pages thereto",
"Form of Warrant to Purchase Shares of Common Stock",
"Securities Purchase Agreement, by and among ARYx Therapeutics, Inc. and the purchasers identified on the signature pages thereto",
"ARYx REPORTS THIRD QUARTER 2008 FINANCIAL RESULTS As a Result of Recent Clinical, Strategic and Financial Progress ARYx is Well Positioned to Achieve its Corporate Milestones"
10/23/2008 8-K Form 8-K -- Current report
08/29/2008 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy